Home
StockRanks™
Platform
Reviews
Pricing

Get started Log in

Sectors Healthcare Biotechnology & Medical ResearchTaysha Gene Therapies

TSHA — Taysha Gene Therapies Share News

$4.510.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
$1.24bn
Enterprise Value
$989.36m
Revenue
$8.33m

Quality
37
Value
8
Momentum
58
StockRank™
25

StockReport™
Accounts
News
TSHA Dividends

StockReport™

Balance sheet

Income statement

Cashflow

News

TSHA Dividends

Company

About us
Careers
Product Guide

Our Coverage

Countries
Sectors
Ratios

Top Stocks

UK Stocks
Australian Stocks
US Stocks

Legals

Privacy Policy
Terms & Conditions
Disclaimer & FSG
Cookies

Select a country/region:

© Stockopedia 2026, Refinitiv, Share Data Services.

*Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.